The effect of neutralizing monoclonal antibodies on early events in Rift Valley fever virus infectivity (Q30416792)

21 June 2017

The effect of neutralizing monoclonal antibodies on early events in Rift Valley fever virus infectivity (English)

1 reference

Rift Valley fever phlebovirus

21 June 2017

0 references

1 reference

1 reference

1 reference

Rift Valley fever virus

object named as

Rift Valley fever virus

1 reference

1 reference

Besselaar TG

1

1 reference

PubMed ID

7517569

21 June 2017

Blackburn NK

series ordinal

2

1 reference

21 June 2017

1 January 1994

1 reference

21 June 2017

1 reference

21 June 2017

145

1 reference

21 June 2017

1

1 reference

21 June 2017

13-19

1 reference

Precise determination of protein antigenic structures has unravelled the molecular immune recognition of proteins and provided a prototype for synthetic mimicking of other protein binding sites

21 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2807%2980002-1

7 January 2021

Antigenic analysis of West Nile virus strains using monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2807%2980002-1

7 January 2021

Topological mapping of antigenic sites on the Rift Valley fever virus envelope glycoproteins using monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2807%2980002-1

7 January 2021

The synergistic neutralization of Rift Valley fever virus by monoclonal antibodies to the envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2807%2980002-1

7 January 2021

Antigenic analysis of Rift valley fever virus isolates: monoclonal antibodies distinguish between wild-type and neurotropic virus strains

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2807%2980002-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0923-2516%2807%2980002-1

1 reference

7 January 2021

Mechanisms of rabies virus neutralization by glycoprotein-specific monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2807%2980002-1

7 January 2021

Identification of antigenic sites on pseudorabies virus glycoprotein gp50 implicated in virus penetration of the host cell

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2807%2980002-1

7 January 2021

Flavivirus Infection Enhancement in Macrophages: Radioactive and Biological Studies on the Effect of Antibody on Viral Fate

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2807%2980002-1

7 January 2021

Epitope model of tick-borne encephalitis virus envelope glycoprotein E: analysis of structural properties, role of carbohydrate side chain, and conformational changes occurring at acidic pH.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2807%2980002-1

7 January 2021

Complete sequences of the glycoproteins and M RNA of Punta Toro phlebovirus compared to those of Rift Valley fever virus

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2807%2980002-1

7 January 2021

Enhanced neutralization of La Crosse virus by the binding of specific pairs of monoclonal antibodies to the G1 glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2807%2980002-1

7 January 2021

The Effect of Proteolytic Cleavage of La Crosse Virus G1 Glycoprotein on Antibody Neutralization

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2807%2980002-1

7 January 2021

Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2807%2980002-1

7 January 2021

10.1016/S0923-2516(07)80002-1

Identifiers

DOI

1 reference

21 June 2017

1 reference

PubMed ID

7517569